Back to Search
Start Over
3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
- Source :
-
Molecular medicine reports [Mol Med Rep] 2015 Jul; Vol. 12 (1), pp. 1247-52. Date of Electronic Publication: 2015 Mar 20. - Publication Year :
- 2015
-
Abstract
- 3,3'-Diindolylmethane (DIM) is the major product of the acid-catalyzed condensation of indole-3-carbinol (I3C), a component of extracts of Brassica food plants. Numerous studies have suggested that DIM has several beneficial biological activities, including elimination of free radicals, antioxidant and anti-angiogenic effects and activation of apoptosis of various tumor cells. In the present study, an in vitro model was established, using 1 µM angiotensin II (Ang II) in cultured rat cardiac H9c2 cells, to observe the effects of DIM on cardiac hypertrophy. Following 24 h stimulation with DIM (1, 5, and 10 µM) with or without Ang II, cells were characterized by immunofluorescence to analyze cardiac α-actinin expression. Cardiomyocyte hypertrophy and molecular markers of cardiac hypertrophy were assessed by quantitative polymerase chain reaction. Atrial natriuretic peptide, brain natriuretic peptide and myosin heavy chain β mRNA expression were induced by Ang II in H9c2 cells treated with the optimal concentration of DIM for 6, 12, and 24 h. The levels of phosphorylated and total proteins of the 5' AMP-activated protein kinase α (AMPKα)/mitogen-activated protein kinase (MAPK)/mechanistic target of rapamycin (mTOR) signaling pathways in H9c2 cells treated with DIM for 0, 15, 30, and 60 min induced by Ang II were determined by western blot analysis. The results showed that DIM attenuated cellular hypertrophy in vitro, enhanced the phosphorylation of AMPKα and inhibited the MAPK‑mTOR signaling pathway in response to hypertrophic stimuli.
- Subjects :
- AMP-Activated Protein Kinases antagonists & inhibitors
AMP-Activated Protein Kinases metabolism
Angiotensin II pharmacology
Animals
Atrial Natriuretic Factor genetics
Atrial Natriuretic Factor metabolism
Cardiomegaly genetics
Cardiomegaly metabolism
Cardiomegaly pathology
Cardiomegaly prevention & control
Cell Line
Gene Expression Regulation
Models, Biological
Myocytes, Cardiac metabolism
Myocytes, Cardiac pathology
Myosin Heavy Chains genetics
Myosin Heavy Chains metabolism
Natriuretic Peptide, Brain genetics
Natriuretic Peptide, Brain metabolism
Phosphorylation drug effects
Rats
Signal Transduction
TOR Serine-Threonine Kinases antagonists & inhibitors
TOR Serine-Threonine Kinases metabolism
Vasoconstrictor Agents antagonists & inhibitors
Vasoconstrictor Agents pharmacology
AMP-Activated Protein Kinases genetics
Cardiotonic Agents pharmacology
Indoles pharmacology
Myocytes, Cardiac drug effects
TOR Serine-Threonine Kinases genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1791-3004
- Volume :
- 12
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Molecular medicine reports
- Publication Type :
- Academic Journal
- Accession number :
- 25816057
- Full Text :
- https://doi.org/10.3892/mmr.2015.3523